DrPaola Dama
Visitor (Life Sciences)
School of Life Sciences
Orcid identifier0000-0001-5716-9665
- Visitor (Life Sciences)School of Life Sciences
BIO
Paola Dama achieved her MS degree in Cellular Biology at University Federico II in Naples (IT).
As an undergraduate student at TIGEM, she worked on the approach of gene therapy in the MSD, a rare metabolic, genetic disease in a mouse model.
She received her Ph.D. in Molecular Oncology at the University of Ferrara (IT) and The Ohio State University in Columbus (OH, USA) under the supervision of Stefano Volinia and the mentoring of Carlo Croce, co-leading a study of miRNAs in pluripotent stem cells and metastasis in invasive breast cancer and gliomas.
She conducted her first post-doctoral studies at the Comprehensive Cancer Center of The Ohio State University, assessing the functional role of key driver candidates of endometrial tumorigenesis. At the University of Chicago Medical Center in Chicago (IL, USA), she specialized in immunotherapy in Leukemias and Lymphomas, using effective methods to detect neoantigens from human tissues and describing the role of checkpoint inhibitors in leukemia patients treated with chemotherapy.
Paola's research at the University of Sussex aims to investigate the role of coding and non-coding alterations on cancer pathogenesis and progression with specific emphasis on developing a new method to identify new miRNAs targets in Pancreatic cancer guided by Crispr/Cas9 and next-generation sequencing technologies.
Since 2020 Paola has collaborated with Mohsen Sheykhhasan of Hamadan University of Medical Sciences, Department of Medicine in Iran. She's also a "popular science" writer, opinion leader, and debunker in her country of origin: Italy. Besides her passion for cancer research, she cares about the job's integrity and communications to the public. She was a founder and president of a Task Force of scientists and the author of the book" Falsa Equivalenza," a compendium of debunking fake news, data, and discussion about the environmental issue named "Land of fire." As a result, she's received awards at an international level for her social commitment and testimonial for STEM.
As an undergraduate student at TIGEM, she worked on the approach of gene therapy in the MSD, a rare metabolic, genetic disease in a mouse model.
She received her Ph.D. in Molecular Oncology at the University of Ferrara (IT) and The Ohio State University in Columbus (OH, USA) under the supervision of Stefano Volinia and the mentoring of Carlo Croce, co-leading a study of miRNAs in pluripotent stem cells and metastasis in invasive breast cancer and gliomas.
She conducted her first post-doctoral studies at the Comprehensive Cancer Center of The Ohio State University, assessing the functional role of key driver candidates of endometrial tumorigenesis. At the University of Chicago Medical Center in Chicago (IL, USA), she specialized in immunotherapy in Leukemias and Lymphomas, using effective methods to detect neoantigens from human tissues and describing the role of checkpoint inhibitors in leukemia patients treated with chemotherapy.
Paola's research at the University of Sussex aims to investigate the role of coding and non-coding alterations on cancer pathogenesis and progression with specific emphasis on developing a new method to identify new miRNAs targets in Pancreatic cancer guided by Crispr/Cas9 and next-generation sequencing technologies.
Since 2020 Paola has collaborated with Mohsen Sheykhhasan of Hamadan University of Medical Sciences, Department of Medicine in Iran. She's also a "popular science" writer, opinion leader, and debunker in her country of origin: Italy. Besides her passion for cancer research, she cares about the job's integrity and communications to the public. She was a founder and president of a Task Force of scientists and the author of the book" Falsa Equivalenza," a compendium of debunking fake news, data, and discussion about the environmental issue named "Land of fire." As a result, she's received awards at an international level for her social commitment and testimonial for STEM.
ACADEMIC POSITIONS
- Research FellowUniversity of Sussex, School of Life sciences, Brighton Falmer, United Kingdom7 May 2019